Publikationen in Zusammenarbeit mit Forschern von NavarraBiomed (4)

2021

  1. Antifibrotic effect of novel neutrophil gelatinase-associated lipocalin inhibitors in cardiac and renal disease models

    Scientific Reports, Vol. 11, Núm. 1

2017

  1. Aldosterone target NGAL (Neutrophil gelatinase-associated lipocalin) is involved in cardiac remodeling after myocardial infarction through NFκB pathway

    Hypertension, Vol. 70, Núm. 6, pp. 1148-1156

  2. Beneficial effects of galectin-3 blockade in vascular and aortic valve alterations in an experimental pressure overload model

    International Journal of Molecular Sciences, Vol. 18, Núm. 8

2015

  1. Neutrophil gelatinase-associated lipocalin, a novel mineralocorticoid biotarget, mediates vascular profibrotic effects of mineralocorticoids

    Hypertension, Vol. 66, Núm. 1, pp. 158-166